| The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases | |
| Chen, Zhe; He, Lu; Li, Lanfang*; Chen, Linxi* | |
| 刊名 | Clinica Chimica Acta
 |
| 2018 | |
| 卷号 | 479页码:196-207 |
| 关键词 | The P2X7 receptor Myocardial ischemia-reperfusion injury Dilated cardiomyopathy Autoimmune myocarditis Atherosclerosis Diabetic retinopathy |
| ISSN号 | 0009-8981 |
| DOI | 10.1016/j.cca.2018.01.032 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000428493600029 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/5676549 |
| 专题 | 南华大学 |
| 作者单位 | 1.[Li, Lanfang 2.Li, LF 3.Chen, Linxi 4.He, Lu 5.Chen, Zhe] Univ South China, Inst Pharm & Pharmacol, Hengyang 421001, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Chen, Zhe,He, Lu,Li, Lanfang*,et al. The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases[J]. Clinica Chimica Acta,2018,479:196-207. |
| APA | Chen, Zhe,He, Lu,Li, Lanfang*,&Chen, Linxi*.(2018).The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases.Clinica Chimica Acta,479,196-207. |
| MLA | Chen, Zhe,et al."The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases".Clinica Chimica Acta 479(2018):196-207. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论